000 | 01740 a2200481 4500 | ||
---|---|---|---|
005 | 20250513235348.0 | ||
264 | 0 | _c20010830 | |
008 | 200108s 0 0 eng d | ||
022 | _a0143-3636 | ||
024 | 7 |
_a10.1097/00006231-200103000-00002 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aVan De Wiele, C | |
245 | 0 | 0 |
_a99Tc(m) labelled HL91 versus computed tomography and biopsy for the visualization of tumour recurrence of squamous head and neck carcinoma. _h[electronic resource] |
260 |
_bNuclear medicine communications _cMar 2001 |
||
300 |
_a269-75 p. _bdigital |
||
500 | _aPublication Type: Clinical Trial; Clinical Trial, Phase I; Comparative Study; Journal Article | ||
650 | 0 | 4 | _aAdult |
650 | 0 | 4 | _aAged |
650 | 0 | 4 | _aBiopsy |
650 | 0 | 4 |
_aCarcinoma, Squamous Cell _xdiagnostic imaging |
650 | 0 | 4 |
_aHead and Neck Neoplasms _xdiagnostic imaging |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aImage Processing, Computer-Assisted |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aMiddle Aged |
650 | 0 | 4 |
_aNeoplasm Recurrence, Local _xdiagnostic imaging |
650 | 0 | 4 |
_aOrganotechnetium Compounds _xadverse effects |
650 | 0 | 4 |
_aOximes _xadverse effects |
650 | 0 | 4 | _aPilot Projects |
650 | 0 | 4 | _aRadiography |
650 | 0 | 4 |
_aRadiopharmaceuticals _xadverse effects |
650 | 0 | 4 | _aReproducibility of Results |
650 | 0 | 4 | _aSafety |
650 | 0 | 4 | _aTomography, Emission-Computed |
700 | 1 | _aVersijpt, J | |
700 | 1 | _aDierckx, R A | |
700 | 1 | _aMoerman, M | |
700 | 1 | _aLemmerling, M | |
700 | 1 | _aD'Asseler, Y | |
700 | 1 | _aVermeersch, H | |
773 | 0 |
_tNuclear medicine communications _gvol. 22 _gno. 3 _gp. 269-75 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1097/00006231-200103000-00002 _zAvailable from publisher's website |
999 |
_c11249159 _d11249159 |